These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 21556030)

  • 1. Intravenous immunoglobulin therapy in rheumatic diseases.
    Bayry J; Negi VS; Kaveri SV
    Nat Rev Rheumatol; 2011 Jun; 7(6):349-59. PubMed ID: 21556030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin therapy for rheumatic diseases.
    Sany J
    Curr Opin Rheumatol; 1994 May; 6(3):305-10. PubMed ID: 8060767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An intravenous immunoglobulin therapy of serious autoimmune rheumatic diseases.
    Lukan N; Lazurova I; Racz O; Kristofova B; Tkac I
    Bratisl Lek Listy; 2008; 109(11):489-92. PubMed ID: 19205557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intravenous immunoglobulin (IVIG)].
    Hara M
    Nihon Rinsho; 2009 Mar; 67(3):599-605. PubMed ID: 19280939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications for IVIG in rheumatic diseases.
    Mulhearn B; Bruce IN
    Rheumatology (Oxford); 2015 Mar; 54(3):383-91. PubMed ID: 25406359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Immunoglobulin in Pediatric Rheumatology: When to Use It and What Is the Evidence.
    Rodriguez MM; Wagner-Weiner L
    Pediatr Ann; 2017 Jan; 46(1):e19-e24. PubMed ID: 28079914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose intravenous immunoglobulin therapy for rheumatic diseases: clinical relevance and personal experience.
    De Vita S; Ferraccioli GF; Di Poi E; Bartoli E; Bombardieri S
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S85-92. PubMed ID: 8828953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of intravenous humana immunoglobulin in rheumatic diseases].
    Mussano ED; Onetti LB; Cadile II; Onetti CM
    Rev Fac Cien Med Univ Nac Cordoba; 2012; 69(2):90-6. PubMed ID: 23286538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indications for intra-venous immunoglobulin treatment in rheumatic diseases].
    Laghi Pansini F; Capecchi PL; Bellisai F; Lazzerini PE; Galeazzi M
    Reumatismo; 2003; 55(4):209-19. PubMed ID: 14872219
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravenous immunoglobulin in the therapeutic armamentarium of systemic lupus erythematosus: a systematic review and meta-analysis.
    Sakthiswary R; D'Cruz D
    Medicine (Baltimore); 2014 Oct; 93(16):e86. PubMed ID: 25310743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of intravenous immunoglobulin in the treatment of rheumatic diseases in adults].
    Swierkot J; Lewandowicz-Uszyńska A
    Pol Merkur Lekarski; 2011 Jun; 30(180):435-40. PubMed ID: 21751555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.
    Gürcan HM; Ahmed AR
    Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous Immunoglobulin as Potential Adjunct Therapy for Interstitial Lung Disease.
    Hallowell RW; Amariei D; Danoff SK
    Ann Am Thorac Soc; 2016 Oct; 13(10):1682-1688. PubMed ID: 27482830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulins for rheumatic disorders and thromboembolic events-a case series and review of the literature.
    Lidar M; Masarwa S; Rotman P; Carmi O; Rabinowicz N; Levy Y
    Immunol Res; 2018 Dec; 66(6):668-674. PubMed ID: 30565202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of antineutrophil cytoplasmic autoantibody-positive systemic vasculitis and glomerulonephritis with pooled intravenous gammaglobulin.
    Tuso P; Moudgil A; Hay J; Goodman D; Kamil E; Koyyana R; Jordan SC
    Am J Kidney Dis; 1992 Nov; 20(5):504-8. PubMed ID: 1442764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin therapy: magic or black magic.
    Barron KS; Sher MR; Silverman ED
    J Rheumatol Suppl; 1992 Apr; 33():94-7. PubMed ID: 1593608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pooled intravenous immunoglobulin in the management of systemic vasculitis.
    Jayne DR; Lockwood CM
    Adv Exp Med Biol; 1993; 336():469-72. PubMed ID: 8296659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intravenously applied immunoglobulin in systemic, autoimmune and vasculitis diseases in children].
    Zeman K; Cywińska-Bernas A
    Pol Merkur Lekarski; 2011 Jun; 30(180):400-4. PubMed ID: 21751547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic principles of intravenous immunoglobulin (IVIg) treatment.
    Stangel M; Pul R
    J Neurol; 2006 Sep; 253 Suppl 5():V18-24. PubMed ID: 16998749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity.
    Jayne DR; Chapel H; Adu D; Misbah S; O'Donoghue D; Scott D; Lockwood CM
    QJM; 2000 Jul; 93(7):433-9. PubMed ID: 10874052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.